Internal Medicine, Pulmonary Disease · Valencia, CA
NPI
1407119738
Since 2012
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
23803 McBean Pkwy #202
Valencia, CA, 91355
Phone (661) 481-2400
Groups this clinician bills Medicare through
Medicare paid, 2024
$74K
985 services
Medicare patients, 2024
230
Average age 75
Drug cost, 2024
$827K
2,327 prescriptions
Company payments, 2025
$391
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wisam S Naji was code 99214 (office e&m - established), 298 times for 148 patients. In total Wisam S Naji billed 985 services in 37 codes, and Medicare paid $74K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 298 | 148 | $97.57 | $29K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 159 | 114 | $13.70 | $2,178 |
| 99233 Hospital E&M - Subsequent | Facility | 127 | 43 | $96.86 | $12K |
| 99291 Critical Care E&M | Facility | 74 | 34 | $172.74 | $13K |
| 99204 Office E&M - New | Office | 52 | 52 | $123.54 | $6,424 |
| J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 51 | 17 | $0.03 | $1.6 |
| 94726 Pulmonary Function Testing | Office | 27 | 27 | $48.85 | $1,319 |
| 94729 Pulmonary Function Testing | Office | 27 | 27 | $46.33 | $1,251 |
| 71046 X-ray - Chest | Office | 24 | 22 | $11.38 | $273 |
| G0008 Administration of influenza virus vaccine | Office | 22 | 22 | $35.02 | $770 |
| 94060 Pulmonary Function Testing | Office | 22 | 22 | $33.32 | $733 |
| 90653 Vaccine Product | Office | 16 | 16 | $81.82 | $1,309 |
| 99223 Hospital E&M - Initial | Facility | 13 | 12 | $142.68 | $1,855 |
| 36415 Venipuncture Blood Collection | Office | 13 | 11 | $8.65 | $112 |
By year: 2022 $73K for 733 services; 2023 $70K for 822 services; 2024 $74K for 985 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 13 | 11 | $8.65 | $112 |
Medicare prescription drug claims, 2024
In 2024, the drug Wisam S Naji prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 396 prescriptions and refills. In total Wisam S Naji wrote 2,327 Medicare prescriptions that cost $827K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 396 | 560 | 78 | $347K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 390 | 481 | 172 | $11K |
| Advair Hfa Fluticasone Propion/Salmeterol | 161 | 222 | 52 | $70K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 129 | 161 | 37 | $70K |
| Spiriva Respimat Tiotropium Bromide | 125 | 157 | 31 | $79K |
| Azelastine Hcl Generic | 115 | 274 | 62 | $2,731 |
| Montelukast Sodium Generic | 107 | 308 | 33 | $1,362 |
| Breo Ellipta Fluticasone/Vilanterol | 92 | 136 | 26 | $51K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 89 | 131 | 25 | $14K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 86 | 106 | 25 | $48K |
| Prednisone Generic | 79 | 99 | 47 | $217 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 63 | 105 | 21 | $12K |
| Azithromycin Generic | 52 | 52 | 37 | $177 |
| Proair Respiclick Albuterol Sulfate | 48 | 51 | 24 | $3,129 |
| Symbicort Budesonide/Formoterol Fumarate | 41 | 63 | 11 | $14K |
Brand drugs: 1,568 claims; generic drugs: 759 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wisam S Naji $391 ($391 in general payments such as food, travel and fees) from 2 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $250.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $250 |
| Abiomed JNJ | 1 | $141 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.